Mega PTH

Mega PTH

teriparatide

Manufacturer:

Mega Lifesciences

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Teriparatide [r-human parathyroid hormone (1-34)]
Indications/Uses
Postmenopausal women w/ osteoporosis at high risk for fracture eg, history of osteoporotic fracture, multiple risk factors for fracture or patients who failed or are intolerant to other available osteoporosis therapy.
Dosage/Direction for Use
Contraindications
Hypersensitivity. Preexisting hypercalcaemia. Severe renal impairment, metabolic bone diseases other than primary osteoporosis (including hyperparathyroidism & Paget's disease of bone), unexplained elevations of alkaline phosphatase, prior external beam or implant RT to the skeleton, patients w/ skeletal malignancies or bone metastases.
Special Precautions
Active or recent urolithiasis. Transient orthostatic hypotension. Concomitant use w/ digitalis. Increase in urinary Ca excretion. Moderate renal impairment. May affect ability to drive or operate machinery. Pregnancy & lactation. Childn.
Adverse Reactions
Nausea, pain in limb, headache & dizziness.
Drug Interactions
Increased serum Ca in concomitant use w/ digoxin.
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
H05AA02 - teriparatide ; Belongs to the class of parathyroid hormones and analogues. Used in the management of calcium homeostasis.
Presentation/Packing
Form
Mega PTH inj 750 mcg/3 mL
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in